Sai Life SciencesNSE:SAILIFE +2.48%18 Days Inventory is 39.54 as of Mar. 2026, which is 8% below its 10-year median of 42.76. GuruFocus rates NSE:SAILIFE with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 178 Medical Diagnostics & Research companies, Sai Life Sciences ranks better than 73.03% on this metric.
The historical rank and industry rank for Sai Life Sciences's Days Inventory or its related term are showing as below:
NSE:SAILIFE'
s Days Inventory Range Over the Past 10 Years
Min: 37.1 Med: 42.76 Max: 76.93
Current: 38.04
During the past 5 years, Sai Life Sciences's highest Days Inventory was 76.93. The lowest was 37.10. And the median was 42.76.
NSE:SAILIFE's Days Inventory is ranked better than 73.03% of 178
companies
in the Medical Diagnostics & Research industry
Industry Median: 68.88
vs NSE:SAILIFE: 38.04
Sai Life Sciences's Days Inventory
increased
from Mar. 2025 (34.02) to Mar. 2026 (39.54).
It might indicate that Sai Life Sciences's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sai Life Sciences's Inventory Turnover for the
three
months ended in Mar. 2026 was 2.31.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sai Life Sciences's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.25.
Sai Life Sciences (NSE:SAILIFE) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sai Life Sciences's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sai Life Sciences's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sai Life Sciences Days Inventory Related Terms
Sai Life Sciences Days Inventory Historical Data
* Premium members only.
The historical data trend for Sai Life Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SAILIFE vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Sai Life Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sai Life Sciences Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Sai Life Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sai Life Sciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sai Life Sciences (NSE:SAILIFE) has a Days Inventory of 39.54 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sai Life Sciences and its competitors. This is near median its historical median of 42.76. Over the past decade, Sai Life Sciences' Days Inventory has ranged from 37.10 to 76.93. According to the industry distribution chart, Sai Life Sciences ranks #48 out of 178 companies in the Medical Diagnostics & Research industry, placing it in the top 27%.
Is Sai Life Sciences' Days Inventory too high?
Sai Life Sciences' current Days Inventory of 39.54 is near median its 10-year median of 42.76. Over the past 10 years, this metric has ranged from a low of 37.10 to a high of 76.93. The Medical Diagnostics & Research industry median Days Inventory is 68.88. Sai Life Sciences' value of 39.54 is 42.6% below this industry median. Based on the distribution chart, Sai Life Sciences ranks #48 out of 178 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Sai Life Sciences has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sai Life Sciences' Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Sai Life Sciences ranks #48 out of 178 companies for Days Inventory. This puts Sai Life Sciences in the upper half of its industry. The industry median Days Inventory is 68.88. Sai Life Sciences' value of 39.54 is 42.6% below this benchmark. Historically, Sai Life Sciences' own Days Inventory has ranged from 37.10 to 76.93 over the past decade. While the company's 10-year median is 42.76 vs. the industry median of 68.88, Sai Life Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 68.88, based on 178 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sai Life Sciences's current Days Inventory of 39.54 is 42.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sai Life Sciences and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 68.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sai Life Sciences's current Days Inventory is 39.54, which is near median its own 10-year median of 42.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Life Sciences stock overvalued right now?
Sai Life Sciences (NSE:SAILIFE) has a current Days Inventory of 39.54. The current Days Inventory is 39.54, which is near median its 10-year median of 42.76 and 42.6% below the Medical Diagnostics & Research industry median of 68.88. Sai Life Sciences' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sai Life Sciences (NSE:SAILIFE), the current Days Inventory is 39.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
18GF Score
Get the complete analysis for NSE:SAILIFE
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAILIFE has been successfully added to your 
